The National Institute of Mental Health awarded a purchase order to Wicell Research Institute, Inc. for $49,115.00 on September 23, 2026, for karyotyping of induced pluripotent stem cell (iPSC) lines with varying sex chromosome dosage. No set-aside was used.
Work is performed at Wicell's facility in Madison, Wisconsin. The purchase order calls for karyotyping analysis of 94 iPSC lines to confirm maintenance of original karyotypes in derived cells and completion of karyotyping analysis reporting. The order is firm fixed price and carries an ultimate completion date of December 31, 2026. The award emerged from solicitation 75N98026Q01088, posted August 26, 2026, which specified NAICS 541990 and authorized sole-source award based on continuity with Wicell's previously established protocols for this work.